Till Örebro universitet

oru.seÖrebro universitets publikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
The risk of renal disease is increased in lambda myeloma with bone marrow amyloid deposits
Region Örebro län. Department of Medicine, Örebro University Hospital, Örebro, Sweden.ORCID-id: 0000-0002-0283-4418
Örebro universitet, Institutionen för medicinska vetenskaper. Region Örebro län. Clinical Epidemiology Unit, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden; Department of Epidemiology and Public Health, University College London, London, UK. (Clinical Epidemiology and Biostatistics)ORCID-id: 0000-0001-6328-5494
Örebro universitet, Institutionen för medicinska vetenskaper. Department of Transfusion Medicine, Faculty of Medical Sciences, Örebro University, Örebro, Sweden. (Clinical Epidemiology and Biostatistics)
Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
2017 (Engelska)Ingår i: Journal of Blood Medicine, ISSN 1179-2736, Vol. 8, s. 29-34Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Background: Light chain amyloidosis (AL) is a rare deposition disease and is present in 10-15% of patients with myeloma (MM). In contrast to symptomatic AL in MM, presence of bone marrow (BM) amyloid deposits (AD) in MM is not connected to kidney damage. Renal AD but not BM-AD occur mostly in MM with lambda paraprotein (lambda MM).

Methods: We investigated amyloid presence in BM clots taken at diagnosis in 84 patients with symptomatic MM and compared disease characteristics in MM with kappa paraprotein (kappa MM)/lambda MM with and without BM-AD.

Results: Lambda MM with BM-AD was compared with kappa MM without BM-AD, kappa MM with BM-AD, and lambda MM without BM-AD: lambda MM with BM-AD patients had a significantly higher mean creatinine level (4.23 mg/dL vs 1.69, 1.14, and 1.28 mg/dL, respectively) and a higher proportion presented with severe kidney failure (6/11 [55%] vs 6/32 [19%], 1/22 [5%], and 3/19 [16%], respectively). Proteinuria was more common in lambda MM with BM-AD patients compared with kappa MM without BM-AD patients (8/11 [73%] vs 5/32 [16%], respectively).

Conclusion: Kidney damage was more common in lambda MM with BM-AD indicating presence of renal AD.

Ort, förlag, år, upplaga, sidor
DOVE Medical Press Ltd. , 2017. Vol. 8, s. 29-34
Nyckelord [en]
plasma cells, neoplasms, amyloidosis, renal insufficiency, proteinuria
Nationell ämneskategori
Hematologi
Identifikatorer
URN: urn:nbn:se:oru:diva-56847DOI: 10.2147/JBM.S129516ISI: 000395472700001PubMedID: 28293126Scopus ID: 2-s2.0-85016315664OAI: oai:DiVA.org:oru-56847DiVA, id: diva2:1085116
Tillgänglig från: 2017-03-28 Skapad: 2017-03-28 Senast uppdaterad: 2024-01-03Bibliografiskt granskad

Open Access i DiVA

Fulltext saknas i DiVA

Övriga länkar

Förlagets fulltextPubMedScopus

Person

Montgomery, ScottBefekadu, RahelHahn-Strömberg, Victoria

Sök vidare i DiVA

Av författaren/redaktören
Kozlowski, PiotrMontgomery, ScottBefekadu, RahelHahn-Strömberg, Victoria
Av organisationen
Region Örebro länInstitutionen för medicinska vetenskaper
I samma tidskrift
Journal of Blood Medicine
Hematologi

Sök vidare utanför DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 510 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf